50 employees
cCAM Biotherapeutics is a pre-clinical stage company that develops immunotherapies for cancer.
2009
cCAM Biotherapeutics Ltd. raised undisclosed on September 15, 2012
Investors: OrbiMed Advisors and Pontifax Venture Capital